Expression of hypoxia-inducible factor-1α and -2α in human choroidal neovascular membranes

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 10, 2009, Pages 1361-1367

  Sheridan, Carl M ^a   Pate, Stephanie ^a   Hiscott, Paul ^a   Wong, David ^b   Pattwell, David M ^a   Kent, David ^c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c Aut Even Hospital   (Ireland)

Author keywords

Choroidalneo vascular membranes; Cytokine expression; Hypoxia; RPE

Indexed keywords

CD34 ANTIGEN; CD68 ANTIGEN; CHROMOGENIC SUBSTRATE; CYTOKERATIN 18; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; VASCULOTROPIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MACROPHAGE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CHOROID; CHOROIDAL NEOVASCULARIZATION; EYE BANKS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KERATINS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINAL PIGMENT EPITHELIUM; STAINING AND LABELING; TISSUE DISTRIBUTION;

EID: 69549118436     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1133-3     Document Type: Article

References (34)

1. Albina JE, Mastrofrancesco B, Vessella JA, Louis CA, Henry WL Jr, Reichner JS (2001) HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha. Am J Physiol Cell Physiol 281:C1971-C1977
2. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864. doi: 10.1038/nm1075
3. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864. doi: 10.1038/nm1075
4. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864. doi: 10.1038/nm1075
5. Clark RA (1988) Overview and general considerations of wound repair. In: Clark RAF, Henson PM (eds) The molecular and cellular biology of wound repair. Plenum Press, New York, pp 3-33
6. Ding K, Scortegagna M, Seaman R, Birch DG, Garcia JA (2005) Retinal disease in mice lacking hypoxia-inducible transcription factor -2alpha. Invest Ophthalmol Vis Sci 46:1010-1016. doi: 10.1167/iovs.04-0788
7. Elson DA, Ryan HE, Snow JW, Johnson R, Arbeit JM (2000) Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res 60:6189-6195
8. Forooghian F, Das B (2007) Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha. Am J Ophthalmol 144:761-768. doi: 10.1016/j.ajo.2007.07.022
9. Forooghian F, Razavi R, Timms L (2007) Hypoxia-inducible factor expression in human RPE cells. Br J Ophthalmol 91:1406-1410. doi: 10.1136/bjo.2007.123125
10. Fraunfelder FW (2005) Pegaptanib for wet macular degeneration. Drugs Today (Barc) 41:703-709. doi: 10.1358/dot.2005.41.11.917340
11. Garcia JA (2006) HIFing the brakes: Therapeutic opportunities for treatment of human malignancies. Sci STKE 2006:e25. doi: 10.1126/ stke.3372006pe25
12. Grossniklaus HE, Ling JX, Wallace TM, Dithmar S, Lawson DH, Cohen C, Elner VM, Elner SG, Sternberg P Jr (2002) Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis 8:119-126
13. Grossniklaus HE, Ling JX, Wallace TM, Dithmar S, Lawson DH, Cohen C, Elner VM, Elner SG, Sternberg P Jr (2002) Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis 8:119-126
14. Gu YZ, Moran SM, Hogenesch JB, Wartman L, Bradfield CA (1998) Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr 7:205-213
15. Hiscott P, Sheridan C, Magee RM, Grierson I (1999) Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res 18:167-190. doi: 10.1016/S1350-9462(98)00024-X
16. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC (2003) Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23:9361-9374. doi: 10.1128/ MCB.23.24.9361-9374.2003
17. Kent D, Sheridan C (2003) Choroidal neovascularization: A wound healing perspective. Mol Vis 9:747-755
18. Kourlas H, Schiller DS (2006) Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: A review. Clin Ther 28:36-44. doi: 10.1016/j.clinthera.2006.01.009
19. Leek RD, Talks KL, Pezzella F, Turley H, Campo L, Brown NS, Bicknell R, Taylor M, Gatter KC, Harris AL (2002) Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Res 62:1326-1329
20. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M (1996) VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 270:H1803-H1811
21. Otani A, Takagi H, Oh H, Koyama S, Ogura Y, Matumura M, Honda Y (2002) Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes. Microvasc Res 64:162-169. doi: 10.1006/mvre.2002.2407
22. Park SK, Dadak AM, Haase VH, Fontana L, Giaccia AJ, Johnson RS (2003) Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): Role of cytoplasmic trapping of HIF-2alpha. Mol Cell Biol 23:4959-4971. doi: 10.1128/ MCB.23.14.4959-4971.2003
23. Pouyssegur J, Dayan F, Mazure NM (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441:437-443. doi: 10.1038/nature04871
24. Ratcliffe PJ, O'Rourke JF, Maxwell PH, Pugh CW (1998) Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 201:1153-1162
25. Ratcliffe PJ, Pugh CW, Maxwell PH (2000) Targeting tumors through the HIF system. Nat Med 6:1315-1316. doi: 10.1038/82113
26. Richards FM (2001) Molecular pathology of von HippelLindau disease and the VHL tumour suppressor gene. Expert Rev Mol Med 2001:1-27
27. Rivard A, Berthou-Soulie L, Principe N, Kearney M, Curry C, Branellec D, Semenza GL, Isner JM (2000) Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem 275:29643-29647. doi: 10.1074/ jbc.M001029200
28. Rosenberger C, Rosen S, Heyman SN (2005) Current understanding of HIF in renal disease. Kidney Blood Press Res 28:325-340. doi: 10.1159/000090187
29. Scheid A, Wenger RH, Christina H, Camenisch I, Ferenc A, Stauffer UG, Gassmann M, Meuli M (2000) Hypoxia-regulated gene expression in fetal wound regeneration and adult wound repair. Pediatr Surg Int 16:232-236. doi: 10.1007/s003830050735
30. Semenza GL (2002) HIF-1 and tumor progression: Pathophysiology and therapeutics. Trends Mol Med 8:S62-S67. doi: 10.1016/ S1471-4914(02)02317-1
31. Semenza GL (2004) Hydroxylation of HIF-1: Oxygen sensing at the molecular level. Physiology (Bethesda) 19:176-182. doi: 10.1152/ physiol.00001.2004
32. Semenza GL, Shimoda LA, Prabhakar NR (2006) Regulation of gene expression by HIF-1. Novartis Found Symp 272:2-8. doi: 10.1002/ 9780470035009.ch2
33. Sheridan CM, Rice D, Hiscott PS, Wong D, Kent DL (2006) The presence of AC133-positive cells suggests a possible role of endothelial progenitor cells in the formation of choroidal neovascularization. Invest Ophthalmol Vis Sci 47:1642-1645. doi: 10.1167/iovs.05-0779
34. Shimada H, Kawamura A, Mori R, Yuzawa M (2007) Clinicopathological findings of retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 245:295-300. doi: 10.1007/s00417-006-0367-6